Gene Therapy - Table of Contents alert Volume 24 Issue 5

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 24, Issue 5 (May 2017) In this issue Comment Original Articles Short Communication Also new AOP Sign up for e-alerts Recommend to your library Web feed Subscribe Twitter Facebook Instagram Advertisement IBS-NATURE CONFERENCE ON FRONTIERS IN GENOME ENGINEERING  September 27-29, 2017 | Seoul, Korea Presented by: Institute for Basic Science | Institute of Genetics and Developmental Biology, CAS | Nature | Nature Biotechnology REGISTER NOW! Comment Top Delivering efficient liver-directed AAV-mediated gene therapy J Baruteau, S N Waddington, I E Alexander and P Gissen Gene Ther 2017 24: 263-264; advance online publication, January 12, 2017; 10.1038/gt.2016.90 Full Text Original Articles Top Deletion of the GAA repeats from the human frataxin gene using the CRISPR-Cas9 system in YG8R-derived cells and mouse models of Friedreich ataxia D L Ouellet, K Cherif, J Rousseau and J P Tremblay Gene Ther 2017 24: 265-274; advance online publication, December 26, 2016; 10.1038/gt.2016.89 Abstract | Full Text An AAVrh10-CAG-CYP21-HA vector allows persistent correction of 21-hydroxylase deficiency in a Cyp21−/− mouse model M Perdomini, C Dos Santos, C Goumeaux, V Blouin and P Bougnères Gene Ther 2017 24: 275-281; advance online publication, February 6, 2017; 10.1038/gt.2017.10 Abstract | Full Text Live-cell imaging to compare the transfection and gene silencing efficiency of calcium phosphate nanoparticles and a liposomal transfection agent OPEN S Chernousova and M Epple Gene Ther 2017 24: 282-289; advance online publication, March 9, 2017; 10.1038/gt.2017.13 Abstract | Full Text Optimization of adeno-associated virus vector-mediated gene transfer to the respiratory tract F Kurosaki, R Uchibori, N Mato, Y Sehara, Y Saga, M Urabe, H Mizukami, Y Sugiyama and A Kume Gene Ther 2017 24: 290-297; advance online publication, March 27, 2017; 10.1038/gt.2017.19 Abstract | Full Text Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells D Hoffmann, J W Schott, F K Geis, L Lange, F-J Müller, D Lenz, D Zychlinski, D Steinemann, M Morgan, T Moritz and A Schambach Gene Ther 2017 24: 298-307; advance online publication, April 20, 2017; 10.1038/gt.2017.20 Abstract | Full Text AAV9-mediated engineering of autotransplanted kidney of non-human primates S Tomasoni, P Trionfini, N Azzollini, L Zentilin, M Giacca, S Aiello, L Longaretti, E Cozzi, N Baldan, G Remuzzi and A Benigni Gene Ther 2017 24: 308-313; advance online publication, March 27, 2017; 10.1038/gt.2017.21 Abstract | Full Text MnSOD mediated by HSV vectors in the periaqueductal gray suppresses morphine withdrawal in rats T Iida, H Yi, S Liu, D Ikegami, W Zheng, Q Liu, K Takahashi, Y Kashiwagi, W F Goins, J C Glorioso and S Hao Gene Ther 2017 24: 314-324; advance online publication, April 3, 2017; 10.1038/gt.2017.22 Abstract | Full Text Short Communication Top Efficient CNS targeting in adult mice by intrathecal infusion of single-stranded AAV9-GFP for gene therapy of neurological disorders K Bey, C Ciron, L Dubreil, J Deniaud, M Ledevin, J Cristini, V Blouin, P Aubourg and M-A Colle Gene Ther 2017 24: 325-332; advance online publication, April 20, 2017; 10.1038/gt.2017.18 Abstract | Full Text Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.